UDD Logo
CRIS - Current Research Information System
New user? Click here to register.Have you forgotten your password?
Communities & Collections
Research Outputs
Fundings & Projects
Researchers
Datasets
Statistics
  1. Home
  2. CRIS
  3. Publications
  4. Differential Effects of a Telemonitoring Platform in the Development of Chemotherapy-Associated Toxicity: A Randomized Trial Protocol
Details

Differential Effects of a Telemonitoring Platform in the Development of Chemotherapy-Associated Toxicity: A Randomized Trial Protocol

Journal
Diagnostics
ISSN
2075-4418
Date Issued
2024
Author(s)
Felipe Martínez
Carla Taramasco
Manuel Espinoza
ACEVEDO ROMO, JOHANNA PATRICIA  
Facultad de Medicina Clínica Alemana Universidad del Desarrollo  
Carolina Goic
Bruno Nervi
Type
journal-article
Scopus ID
2-s2.0-85189167460
WoS ID
WOS:001191915500001
DOI
10.3390/diagnostics14060619
URL
https://investigadores.udd.cl/handle/123456789/10064
Abstract
<jats:p>Chemotherapy requires careful monitoring, but traditional follow-up approaches face significant challenges that were highlighted by the COVID-19 pandemic. Hence, exploration into telemonitoring as an alternative emerged. The objective is to assess the impact of a telemonitoring platform that provides clinical data to physicians overseeing solid tumor patients, aiming to enhance the care experience. The methodology outlines a parallel-group randomized clinical trial involving recently diagnosed patients with solid carcinomas preparing for curative intent chemotherapy. Eligible adult patients diagnosed with specific carcinoma types and proficient in Spanish, possessing smartphones, will be invited to participate. They will be randomized using concealed allocation sequences into two groups: one utilizing a specialized smartphone application called Contigo for monitoring chemotherapy toxicity symptoms and accessing educational content, while the other receives standard care. Primary outcome assessment involves patient experience during chemotherapy using a standardized questionnaire. Secondary outcomes include evaluating severe chemotherapy-associated toxicity, assessing quality of life, and determining user satisfaction with the application. The research will adhere to intention-to-treat principles. This study has been registered at ClinicalTrials.gov (NCT06077123).</jats:p>
Cite this document
Martínez, F., Taramasco, C., Espinoza, M., Acevedo, J., Goic, C., & Nervi, B. (2024). Differential effects of a telemonitoring platform in the development of chemotherapy-associated toxicity: A randomized trial protocol. Diagnostics, 14(6), 619. https://doi.org/10.3390/diagnostics14060619
Project(s)
CENTRO PARA LA PREVENCIÓN Y EL CONTROL DEL CÁNCER (CECAN)  
Subjects
telemonitoring

; 

cancer

; 

surveillance
Logo Universidad de Desarrollo
Encuéntranos en:

Sede Santiago

Av. Plaza 680, Las Condes

Contacto|Mapa

Sede Concepción

Ainavillo 456, Concepción

Contacto|Mapa

Hosting & SupportLogo Scimago Lab

Built with DSpace-CRIS software - Extension maintained and optimized by 4science

  • Accessibility settings
  • Privacy policy
  • End User Agreement
  • Send Feedback
Repository logo COAR Notify